CECILY MILLER: Open Payments
NPI 1205557527 · DURHAM, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$371 in 21 payments from 6 companies in 2025. Trend: 2023 $1,202 · 2024 $1,808 · 2025 $371
Food & beverage: $371
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 15 | $251 |
| Janssen Pharmaceuticals, Inc | 1 | $33 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $33 |
| Vanda Pharmaceuticals Inc. | 1 | $24 |
| Otsuka America Pharmaceutical, Inc. | 1 | $16 |
| Bausch Health US, LLC | 1 | $14 |
Products named: VRAYLAR, SPRAVATO, CAPLYTA, FANAPT, REXULTI, APLENZIN.
Industry payments across NC — which companies pay providers there.
